Resting phase-administration of lemborexant ameliorates sleep and glucose tolerance in type 2 diabetic mice.
Tsuneki H, Sugiyama M, Sato K, Ito H, Nagai S, Kon K, Wada T, Kobayashi N, Okada T, Toyooka N, Kawasaki M, Ito T, Otsubo R, Okuzaki D, Yasui T, Sasaoka T.
Tsuneki H, et al.
Eur J Pharmacol. 2023 Dec 15;961:176190. doi: 10.1016/j.ejphar.2023.176190. Epub 2023 Nov 11.
Eur J Pharmacol. 2023.
PMID: 37952563
Free article.